Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 1 · 33.3%High 0 · 0%

Adverse events · Patients with active Crohn's disease

Antibiotic with anti‐TNF showed no clear difference in adverse events compared with placebo with anti‐TNF (moderate certainty).

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
RR 0.93 [0.76, 1.12]
2 studies · 100 participants
Moderate

Serious adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · Patients with active Crohn's disease

Antibiotic with anti‐TNF showed no clear difference in withdrawal due to adverse events compared with placebo with anti‐TNF (low certainty).

1 finding from 1 review

Antibiotics for induction and maintenance of remission in Crohn's disease 2019 · Cochrane Headline outcomes only
RR 0.82 [0.19, 3.45]
2 studies · 100 participants
Low